Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.980
-0.080 (-1.97%)
At close: Nov 13, 2026, 4:00 PM EST
4.095
+0.115 (2.89%)
After-hours: Nov 13, 2026, 5:59 PM EST

Opus Genetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
38513938687365
Market Cap Growth
190.52%268.99%-44.87%-7.23%13.82%-8.29%
Enterprise Value
3321091265942
Last Close Price
3.982.011.193.013.533.73

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----4.11-
Forward PE
-6.026.026.0214.08-
PS Ratio
48.619.773.423.581.84109.56
PB Ratio
9.929.031.471.371.592.90
P/TBV Ratio
10.019.035.591.371.592.90
P/FCF Ratio
----5.13-
P/OCF Ratio
----5.13-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
41.907.670.091.351.4971.13
EV/EBITDA Ratio
----3.26-
EV/EBIT Ratio
----3.26-
EV/FCF Ratio
----4.16-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.930.07---0.02
Net Debt / Equity Ratio
-1.38-2.86-1.19-1.01-0.92-1.09
Net Debt / EBITDA Ratio
0.861.140.894.79-2.341.07
Net Debt / FCF Ratio
1.091.251.1945.43-2.981.24
Asset Turnover
0.120.330.240.371.060.03
Quick Ratio
9.396.203.2013.0817.276.42
Current Ratio
9.656.433.2413.3517.796.76
Return on Equity (ROE)
-615.57%-242.41%-152.46%-20.77%52.26%-1295.10%
Return on Assets (ROA)
-58.54%-55.39%-46.90%-12.83%30.35%-64.86%
Return on Invested Capital (ROIC)
----503.67%-
Return on Capital Employed (ROCE)
-72.00%-90.90%-133.30%-21.20%39.40%-102.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-37.63%-35.77%-153.15%-14.66%24.35%-87.85%
FCF Yield
-12.67%-25.43%-68.08%-1.63%19.49%-30.17%
Buyback Yield / Dilution
-83.71%-132.91%-23.74%-4.82%-38.68%-218.65%
SEC Filings: 10-K · 10-Q